Replimune Group, Inc.
NASDAQ:REPLBiotechnology
Healthcare
$19.81 +1.85%
+$0.19 today
- Market cap
- $1.88B
- Beta
- 0.91
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$3.42
52W Low $1.50High $13.24
Volume 2.13M
Average 7.51M
Private 5-step workspace
Build a REPL investment thesis
Turn Replimune Group, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.